Used in neuroscience research to quantify TAU protein levels in biological samples such as cerebrospinal fluid, plasma, or tissue extracts. Widely applied in studies related to neurodegenerative diseases, especially Alzheimer's disease, where abnormal TAU accumulation is a key biomarker. Enables researchers to monitor disease progression, evaluate therapeutic efficacy in preclinical models, and support the development of diagnostic tools. Suitable for high-throughput screening and provides a reliable, sensitive method for detecting both normal and hyperphosphorylated forms of TAU protein.